AI for Improved PET/CT Attenuation Correction in Prostate Cancer Imaging

Oncotarget

July 11, 2024
In this new study, researchers investigated an artificial intelligence (AI) tool that produces attenuation-corrected PET images while reducing radiation exposure for patients. continue reading »

Targeting Mitophagy as a Therapeutic Strategy for Cancer Treatment

Aging

June 28, 2024
In this new study, researchers investigated the intricate link between mitophagy and cancer stem cells. continue reading »

The Aging Brain and Peripheral Vascular Dysfunction

Aging

June 12, 2024
PRESS RELEASE: A new review was published in Aging’s Volume 16, Issue 10, entitled, “Peripheral vascular dysfunction and the aging brain.” continue reading »

Dr. Blagosklonny’s Strategy: From Osimertinib to Preemptive Combinations

Oncotarget

June 6, 2024
This article dissects Dr. Mikhail V. Blagosklonny’s paradigm-shifting perspective on preemptive combinations for treating EGFR-mutant non-small cell lung cancer. continue reading »

Synergistic Cytotoxicity of HDAC and PARP Inhibitors and Decitabine in Pancreatic Cancer Cells: Implications for Novel Therapy

News

June 5, 2024
PRESS RELEASE: On June 3, 2024, a new research paper was published in Oncotarget, entitled, “Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy.” continue reading »